Bid to win the chance for you and a lucky guest to have a private dinner with Hollywood's Rising Star, Rafi Gavron, at his favorite restaurant in NYC!
Currently, Rafi stars in Bradley Cooper’s A Star Is Born, opposite Lady Gaga and Bradley Cooper. The film premiered at The Venice and Toronto International Film Festivals to rave reviews from critics around the world and is garnering Oscar buzz for Best Picture. Rafi is a British actor who gained international recognition for his breakout performance as the lead role in Breaking and Entering directed by Anthony Minghella and starring Jude Law, Juliette Binoche and Robin Wright. Since his debut and being dubbed the “Most Exciting New Face of 2006.” Rafi continues to dazzle audiences worldwide playing a range of complex characters in both film and television.
Rafi has starred in Nick and Norah’s Infinite Playlist opposite Michael Cera and Kat Dennings; Inkheart co-starring Brendan Fraser, Paul Bettany and Helen Mirren; Snitch; Celeste and Jesse Forever opposite Rashida Jones; and The Land opposite Erykah Badu and Michael K. Williams. Rafi’s television credits include recurring roles in the HBO series Rome, NBC’s critically acclaimed drama series Parenthood and Fox’s action drama series 24 opposite Kiefer Sutherland.
In November, Rafi will be seen recurring in Amazon's drama series Homecoming opposite Julia Roberts and Bobby Cannavale. Next spring, he will star in George Clooney’s highly anticipated World War II series, CATCH-22 for Hulu opposite Kyle Chandler, Hugh Laurie and Christopher Abbot. Rafi will also return as ‘Edgar’ in the second season of Starz's series Counterpart opposite Oscar Winner, J.K. Simmons. Rafi is currently shooting the crime drama series Godfather of Harlem opposite Forest Whitaker. The series is inspired by the true story of infamous crime boss, Bumby Johnson reign in 1960's Harlem.
Notice of Updated Buyer Terms of Use
We have recently updated our Buyer Terms of Use. We encourage you to review the revised terms to ensure continued understanding and compliance. By continuing to use our platform, you acknowledge and agree to the updated terms. View the updated Terms of Use